Buyout activity rebounded in the third quarter as lockdown restrictions eased across Europe, according to the latest Unquote Private Equity Barometer, produced in association with Aberdeen Standard Investments.
Private Equity
GPs like targeting banks during downturns, investing in stronger players at discount valuations and backing them to come out the other side with increased market share. Will it be more of the same with COVID-19?
-
Fundraising focus shifts to China venture, but it’s the same polarization story; upturn in trade and secondary sales suggests the COVID-19 freeze is thawing; healthcare retains its investment appeal
-
Going on the offensive is the best response to COVID-19 - taking advantage of market uncertainty to make new investments and help portfolio companies complete bolt-on acquisitions - the AVCJ Forum heard.
-
-
-
-
-
Secondaries activity is recovering from the initial coronavirus-related shock, with good prospects for GP-led secondaries deals. Harriet Matthews speaks to David Swanson of Unigestion to discuss the market outlook
-
GPs' relationships with their existing banks and debt funds became crucial to navigating challenging liquidity situations and potential covenant breaches in Q2, and will be even more important in managing the ongoing consequences of the crisis. Harriet Matthews reports
-
Following another period of lacklustre exit activity in Q3, even as deployment was picking up, October saw a notable spike in divestments by PE players across Europe.
-
No more items to load
Load moreAn error occurred trying to play the stream. Please reload the page and try again.
Close